# Brickell Historical Financial Ratios

BBI | Stock | ## USD 3.36 0.09 2.75% |

Brickell Biotech is presently reporting on over 69 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Accounts Payable Turnover of 2.36, Accrued Expenses Turnover of 0.54 or Cash and Equivalents Turnover of 0.0816 will help investors to properly organize and evaluate Brickell Biotech financial condition quickly. Financial Statement Analysis is way more than just reviewing and evaluating Brickell Biotech prevailing accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Brickell Biotech is a good buy for the upcoming year.

Continue to Trending Equities.Brickell |

## About Brickell Financial Ratios Analysis

Brickell BiotechFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Brickell Biotech investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Brickell financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Brickell Biotech history.

## Brickell Biotech Financial Ratios Chart

Brickell Biotech financial ratios usually calculated using numerical values taken directly from Brickell Biotech financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about Brickell Biotech. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.

Brickell Biotech Accrued Expenses Turnover is most likely to slightly decrease in the upcoming years. The last year's value of Accrued Expenses Turnover was reported at 0.52. The current Cash and Equivalents Turnover is estimated to increase to 0.08, while Operating Margin is projected to decrease to (120.19) . Add Fundamental

## Return on Average Assets

Return on assets measures how profitable a company is Net Income Common Stock relative to its total assets [AssetsAvg].## Return on Average Equity

Return on equity measures a corporation's profitability by calculating the amount of Net Income Common Stock returned as a percentage of [EquityAvg].## Return on Sales

Return on Sales is a ratio to evaluate a company's operational efficiency; calculated by dividing Earning Before Interest and Taxes EBIT by Revenues. ROS is often a component of DuPont ROE analysis.Most ratios from Brickell Biotech fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Brickell Biotech current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Continue to Trending Equities.Brickell Biotech Accrued Expenses Turnover is most likely to slightly decrease in the upcoming years. The last year's value of Accrued Expenses Turnover was reported at 0.52. The current Cash and Equivalents Turnover is estimated to increase to 0.08, while Operating Margin is projected to decrease to (120.19) .

2017 | 2018 | 2021 | 2022 (projected) | |

Accounts Payable Turnover | 17.96 | 2.0 | 2.3 | 2.36 |

PPandE Turnover | 15.54 | 4.59 | 4.14 | 4.69 |

## Brickell Biotech fundamentals Correlations

**Click cells**to compare fundamentals

## Brickell Biotech Account Relationship Matchups

### High Positive Relationship

### High Negative Relationship

## Brickell Biotech fundamentals Accounts

2017 | 2018 | 2019 | 2020 | 2021 | 2022 (projected) | ||

PPandE Turnover | 9.29 | 9.51 | 15.54 | 4.59 | 4.14 | 4.69 | |

Accounts Payable Turnover | 43.65 | 27.37 | 17.96 | 2.0 | 2.3 | 2.36 | |

Accrued Expenses Turnover | 5.14 | 4.15 | 3.54 | 0.45 | 0.52 | 0.54 | |

Cash and Equivalents Turnover | 1.24 | 1.57 | 0.92 | 0.0884 | 0.0795 | 0.0816 | |

Return on Investment | (19.33) | (20.27) | (24.63) | (34.98) | (31.48) | (33.96) | |

Revenue to Assets | 0.42 | 0.28 | 0.17 | 0.031 | 0.39 | 0.31 | |

Total Assets Per Share | 33.12 | 25.84 | 16.79 | 2.14 | 2.46 | 2.53 | |

Quick Ratio | 3.91 | 3.12 | 11.29 | 0.39 | 0.45 | 0.46 | |

Net Current Assets as percentage of Total Assets | 77.89 | 73.79 | 87.15 | 41.18 | 47.36 | 67.91 | |

Book Value per Share | 1.55 K | (5.49 K) | 112.75 | 49.81 | 13.96 | 14.32 | |

Current Ratio | 4.51 | 0.41 | 1.71 | 5.28 | 6.15 | 6.47 | |

Debt to Equity Ratio | 0.27 | (0.31) | 1.4 | 0.24 | 0.19 | 0.23 | |

EBITDA Margin | (0.88) | (0.74) | (2.75) | (11.47) | (97.48) | (100.05) | |

Enterprise Value over EBITDA | (1.74) | (1.04) | (1.66) | (0.21) | (1.05) | (0.13) | |

Free Cash Flow per Share | (212.18) | 303.21 | (535.71) | (36.82) | (20.27) | (21.88) | |

Gross Margin | 0.48 | 0.57 | 0.53 | 1.0 | 1.15 | 0.93 | |

Profit Margin | (0.94) | (1.39) | (1.72) | (11.48) | (97.71) | (100.28) | |

Price to Book Value | 0.36 | (0.36) | 1.55 | 1.54 | 1.06 | 1.21 | |

Price to Earnings Ratio | (1.81) | (0.32) | (0.33) | (0.92) | (0.47) | (0.5) | |

Price to Sales Ratio | 1.71 | 0.45 | 0.57 | 10.5 | 45.51 | 49.1 | |

Return on Average Assets | (0.22) | (0.33) | (0.39) | (0.83) | (1.3) | (1.33) | |

Return on Average Equity | (0.28) | (0.66) | (0.49) | (1.17) | (1.64) | (1.68) | |

Return on Invested Capital | (0.4) | (0.28) | (1.08) | 15.83 | 15.43 | 16.65 | |

Return on Sales | (0.94) | (0.75) | (2.75) | (11.48) | (97.54) | (100.1) | |

Sales per Share | 456.86 | 337.76 | 834.74 | 117.85 | 3.35 | 0.23 | |

Tangible Assets Book Value per Share | 1.95 K | 636.94 | 270.09 | 61.74 | 16.65 | 17.09 |

## Brickell Biotech Investors Sentiment

The influence of Brickell Biotech's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Brickell. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Investor biases related to Brickell Biotech's public news can be used to forecast risks associated with investment in Brickell. The trend in average sentiment can be used to explain how an investor holding Brickell can time the market purely based on public headlines and social activities around Brickell Biotech. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.

Brickell Biotech's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Brickell Biotech's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Brickell Biotech's news discussions. The higher the estimate score, the more favorable is the investor's outlook on Brickell Biotech.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Brickell Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Brickell Biotech's short interest history, or implied volatility extrapolated from Brickell Biotech options trading.

## Pair Trading with Brickell Biotech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Brickell Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brickell Biotech will appreciate offsetting losses from the drop in the long position's value.### Moving together with Brickell Biotech

0.69 | AGTC | Applied Genetic Tech | Fiscal Year End 22nd of September 2022 | PairCorr |

### Moving against Brickell Biotech

0.91 | AGL | Agilon Health | Downward Rally | PairCorr | |||

0.81 | AVXL | Anavex Lf SC | Fiscal Year End 23rd of November 2022 | PairCorr | |||

0.79 | ARWR | Arrowhead Pharma | Fiscal Year End 28th of November 2022 | PairCorr | |||

0.75 | AXSM | Axsome Thera | Trending | PairCorr |

The ability to find closely correlated positions to Brickell Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Brickell Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Brickell Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Brickell Biotech to buy it.

The correlation of Brickell Biotech is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Brickell Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Brickell Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Brickell Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Continue to Trending Equities. Note that the Brickell Biotech information on this page should be used as a complementary analysis to other Brickell Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

## Complementary Tools for Brickell Stock analysis

When running Brickell Biotech price analysis, check to measure Brickell Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brickell Biotech is operating at the current time. Most of Brickell Biotech's value examination focuses on studying past and present price action to predict the probability of Brickell Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Brickell Biotech's price. Additionally, you may evaluate how the addition of Brickell Biotech to your portfolios can decrease your overall portfolio volatility.

Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios | Go | |

Stock ScreenerFind equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | Go | |

Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios | Go | |

Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | Go | |

Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges | Go | |

Piotroski F ScoreGet Piotroski F Score based on binary analysis strategy of nine different fundamentals | Go | |

Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. | Go | |

Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges | Go | |

Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum | Go | |

Fundamental AnalysisView fundamental data based on most recent published financial statements | Go | |

Content SyndicationQuickly integrate customizable finance content to your own investment portal | Go | |

Focused OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences | Go | |

Risk-Return AnalysisView associations between returns expected from investment and the risk you assume | Go |

Is Brickell Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brickell Biotech. If investors know Brickell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brickell Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Market Capitalization 8.9 M | Quarterly Revenue Growth YOY 4.41 | Return On Assets -0.85 | Return On Equity -1.76 |

The market value of Brickell Biotech is measured differently than its book value, which is the value of Brickell that is recorded on the company's balance sheet. Investors also form their own opinion of Brickell Biotech's value that differs from its market value or its book value, called intrinsic value, which is Brickell Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brickell Biotech's market value can be influenced by many factors that don't directly affect Brickell Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Brickell Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Brickell Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brickell Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.